Acute Myocardial Infarction Study in Northeastern China

NCT04451967 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3159

Last updated 2020-06-30

No results posted yet for this study

Summary

This is a real-world prospective cohort study aiming to generate knowledge about the characteristics, treatments, and outcomes of hospitalized AMI patients in Jilin Province. The study includes hospitalizations diagnosed of AMI, including ST segment-elevation myocardial infarction (STEMI) and non-ST-segment-elevation myocardial infarction (NSTEMI).

Conditions

  • Acute Myocardial Infarction

Interventions

PROCEDURE

thrombolysis

transfer after thrombolysis for STEMI patients within 6h since onset

Sponsors & Collaborators

  • Yanbian University Hospital

    collaborator UNKNOWN
  • Dunhua City Hospital in Jilin Province

    collaborator UNKNOWN
  • Liaoyuan City Central Hospital

    collaborator UNKNOWN
  • Dongliao People's Hospital

    collaborator UNKNOWN
  • Songyuan Central Hospital

    collaborator UNKNOWN
  • Changling People's Hospital

    collaborator UNKNOWN
  • Siping Central People's Hospital

    collaborator OTHER
  • The First People's Hospital of Manchu Autonomous County

    collaborator UNKNOWN
  • Changchun Center Hospital

    collaborator UNKNOWN
  • Nongan People's Hospital

    collaborator UNKNOWN
  • Beihua University

    collaborator OTHER
  • Jilin Hospital of Integrated Traditional Chinese and Western Medicine

    collaborator UNKNOWN
  • Panshi City Hospital

    collaborator UNKNOWN
  • Tonghua Central Hospital

    collaborator UNKNOWN
  • Baishan Central Hospital

    collaborator UNKNOWN
  • Jingyu People's Hospital

    collaborator UNKNOWN
  • Meihekou Central Hospital

    collaborator UNKNOWN
  • Baicheng Central Hospital

    collaborator UNKNOWN
  • Tongyu First Hospital

    collaborator UNKNOWN
  • Second Hospital of Jilin University

    lead OTHER

Principal Investigators

  • Bin Liu, Ph.D · Second Hospital of Jilin University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-09
Primary Completion
2020-09-09
Completion
2022-09-09

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04451967 on ClinicalTrials.gov